Pulled in another 2K shares more today morning at 2.46.
Bear raid was propelled by some misconceptions and over expectations. The over expectations are still justified but the data was not understood properly by the reviewers hence the selloff. Some major folks left so it will not likely be a very quick turnaround but when additional catalysts happen (resubmission of the revised IAP inhibitor trial proposal) we might have new/old investors move in and a rally.
Overall the latest articles clarifying the study positions have been extremely helpful to understand the situation better and I wouldn't worry about the price on the short run. Just remain focused on the long and it should do good. They clearly stated that they are focussing on the diffuse follicular lymphoma and multiple myelomas (2 pretty nasty conditions) with relatively no competition.
Sentiment as of now: STRONG BUY!!!